Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Allograft Size Graft Code DermaPure Decellularized Dermal Allograft 1 cm x 2 cm 010200HD 2 cm x 2 cm 020200HD 2 cm x 3 cm 020300HD 3 cm x 4 cm 030400HD 4 cm x 6 cm 040600HD DERMAL ALLOGRAFTS dCELL Technology utilizes an elegant proprietary process. Allografts produced using dCELL Technology maintain a very high degree of the properties deemed essential for an environment conducive to effective tissue regeneration. dCELL Technology does not rely on the use of high-concentration detergents that may compromise tissue structure dCELL Technology does not involve the use of chemical xatives which can impede native cell migration DermaPure is appropriate for use in all clinical settings.2 DermaPure generally requires no surgical setting general anesthetic or hospital stay. DermaPure requires no thawing no rehydrating no special storage. DermaPure is stored at ambient temperature and comes hydrated with only a simple rinse required prior to use. For all orders please contact Tissue Regenix at 1-855-452-0133 or www.tissueregenixus.com 31 DermaPure allografts are available in ve convenient sizes. References 1. International consensus Acellular matrices for the treatment of wounds an expert working group review. London Wounds International 2010. 2. Greaves NS Benatar B Baguneid M Bayat A. Single-stage application of a novel decellularized dermis for treatment-resistant lower limb ulcers Positive outcomes assessed by SIAscopy laser perfusion and 3D imaging with sequential timed histological analysis. Wound Repair Regen. 2013216 812-822.